FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $342,507 | -43.4% | 161,560 | +27.1% | 0.00% | – |
Q2 2023 | $605,139 | +4.3% | 127,130 | +24.9% | 0.00% | – |
Q1 2023 | $580,260 | -80.9% | 101,800 | -66.3% | 0.00% | -100.0% |
Q4 2022 | $3,045,162 | +33.5% | 301,800 | +196.5% | 0.00% | 0.0% |
Q3 2022 | $2,281,000 | -35.1% | 101,800 | -28.2% | 0.00% | -50.0% |
Q2 2022 | $3,514,000 | -36.1% | 141,790 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $5,503,000 | -33.6% | 141,947 | +0.3% | 0.00% | -33.3% |
Q4 2021 | $8,284,000 | -1.3% | 141,590 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $8,392,000 | -32.0% | 141,590 | -0.4% | 0.00% | -40.0% |
Q2 2021 | $12,341,000 | +15.9% | 142,190 | +10.1% | 0.01% | 0.0% |
Q1 2021 | $10,650,000 | +18.1% | 129,170 | +30.2% | 0.01% | +25.0% |
Q4 2020 | $9,020,000 | +146.9% | 99,200 | +8.5% | 0.00% | +100.0% |
Q3 2020 | $3,653,000 | +24.1% | 91,400 | +6.5% | 0.00% | 0.0% |
Q2 2020 | $2,944,000 | +64.3% | 85,800 | +6.3% | 0.00% | +100.0% |
Q1 2020 | $1,792,000 | +28.5% | 80,700 | +13.2% | 0.00% | 0.0% |
Q4 2019 | $1,395,000 | +31.1% | 71,300 | +4.1% | 0.00% | 0.0% |
Q3 2019 | $1,064,000 | -23.5% | 68,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,391,000 | +32.4% | 68,500 | +14.5% | 0.00% | 0.0% |
Q1 2019 | $1,051,000 | +42.0% | 59,800 | +3.6% | 0.00% | 0.0% |
Q4 2018 | $740,000 | +6.6% | 57,700 | +35.4% | 0.00% | – |
Q3 2018 | $694,000 | +121.7% | 42,600 | +54.3% | 0.00% | – |
Q2 2018 | $313,000 | +192.5% | 27,600 | +150.9% | 0.00% | – |
Q1 2018 | $107,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |